Clinical Report: Copeptin's Role in ED Admissions for Hypotonic Hyponatremia
Overview
This study evaluated copeptin's utility in assessing extracellular fluid volume and predicting mortality in adults with hypotonic hyponatremia admitted to the emergency department. The copeptin-to-urinary sodium ratio improved identification of preserved extracellular fluid volume and copeptin levels predicted both in-hospital and 6-month mortality.
Background
Hypotonic hyponatremia is a common electrolyte disturbance encountered in hospitalized patients and can cause serious neurological symptoms due to plasma hypotonicity. Accurate diagnosis and timely treatment in the emergency department are critical. Copeptin, a stable surrogate marker of arginine vasopressin, has shown mixed results in hyponatremia evaluation but may correlate better with plasma osmolality and predict clinical outcomes. Given conflicting evidence, this study aimed to clarify copeptin's diagnostic and prognostic value in hypotonic hyponatremia at ED admission.
Data Highlights
Parameter
Cutoff
Outcome
Statistic
P Value
Copeptin-to-urinary sodium ratio
≤29.5 pmol/mmol
Preserved extracellular fluid volume
Odds ratio 4.28
0.026
Copeptin
>60.1 pmol/L
In-hospital mortality prediction
Hazard ratio 1.005
0.0005
Copeptin
>13.6 pmol/L
6-month mortality risk
Hazard ratio 4.507
0.0001
NT-proBNP
Not specified
6-month mortality prediction
Hazard ratio 1.004
0.031
Charlson Comorbidity Index
Not specified
6-month mortality prediction
Hazard ratio 1.207
0.009
Key Findings
A copeptin-to-urinary sodium ratio ≤29.5 pmol/mmol significantly increased the likelihood of preserved extracellular fluid volume by over 4-fold, outperforming standard urinary sodium cutoff.
Copeptin levels >60.1 pmol/L predicted in-hospital mortality with high statistical significance.
Copeptin measurement at ED admission aids in both diagnostic classification of hypotonic hyponatremia and mortality risk stratification.
Copeptin correlates better with plasma osmolality than arginine vasopressin and is less affected by preanalytical issues.
Clinical Implications
Measuring copeptin and calculating the copeptin-to-urinary sodium ratio in patients presenting with hypotonic hyponatremia can improve extracellular fluid volume assessment and guide appropriate management. Additionally, copeptin levels provide valuable prognostic information regarding in-hospital and 6-month mortality, supporting its use as a biomarker in emergency settings to identify high-risk patients.
Conclusion
Copeptin measurement on emergency department admission enhances diagnostic accuracy for extracellular fluid volume status and serves as a robust predictor of mortality in hypotonic hyponatremia. Incorporating copeptin testing may improve clinical decision-making and patient outcomes.
References
IPSO-URG Study Group 2023 -- Evaluating Copeptin's Significance in Emergency Department Admissions for Patients with Hypotonic Hyponatremia
